2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00231140 (ClinicalTrials.gov)	December 2005	30/9/2005	Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)	Randomized, Open, Parallel Group Study for the Evaluation of an Oral Dose of 100 mg Thalidomideand S ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: Thalidomide (drug)	Charite University, Berlin, Germany	NULL	Terminated	25 Years	80 Years	Both	40	Phase 2	Germany
2	NCT00140452 (ClinicalTrials.gov)	February 2005	31/8/2005	Phase II Study Using Thalidomide for the Treatment of ALS	Phase II Study Using Thalidomide for the Treatment of Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis;ALS	Drug: Thalidomide	Dartmouth-Hitchcock Medical Center	Celgene Corporation	Completed	18 Years	80 Years	Both	24	Phase 2	United States

First Previous1Next Last